marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
NovaBay Pharmaceuticals Balance Sheet 2011-2024 | NBY
Annual Balance Sheet NovaBay Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-1.53 M | -3.32 M | -7.06 M | -11.8 M | -2.89 M | -3.18 M | -3.2 M | -9.51 M | -730 K | -5.43 M | -10.5 M | -12.7 M | -8.43 M |
Long Term Debt |
1.11 M | 1.59 M | 246 K | 87 K | - | - | - | - | 1.66 M | - | - | - | - |
Long Term Debt Current |
495 K | 453 K | 200 K | 416 K | 930 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 87 K | 4.56 M | 560 K | 2.51 M | 3.96 M | 5.54 M | 2.34 M | 3.51 M | 2.01 M | 3.78 M |
Total Current Liabilities |
4.28 M | 4.26 M | 3.44 M | 2.83 M | 5.69 M | 3.85 M | 4.98 M | 4.32 M | 4.63 M | 3.34 M | 3.63 M | 3.17 M | 2.84 M |
Total Liabilities |
5.72 M | 5.84 M | 13.8 M | 2.92 M | 10.2 M | 4.41 M | 7.48 M | 8.28 M | 10.2 M | 5.69 M | 7.13 M | 5.19 M | 6.62 M |
Deferred Revenue |
- | - | 54 K | 730 K | 822 K | 2.32 M | 2.84 M | 2.07 M | 170 K | 425 K | 337 K | 1.22 M | 1.3 M |
Retained Earnings |
-175 M | -158 M | -142 M | -136 M | -125 M | -115 M | -111 M | -104 M | -90.5 M | -71.5 M | -56.4 M | -40.3 M | -33.3 M |
Total Assets |
9.03 M | 16.4 M | 24 M | 15.2 M | 11.2 M | 9.36 M | 10.1 M | 15.4 M | 5.08 M | 7.54 M | 15.6 M | 19.2 M | 16 M |
Cash and Cash Equivalents |
3.13 M | 5.36 M | 7.5 M | 12 M | 6.94 M | 3.18 M | 3.2 M | 9.51 M | 2.38 M | 5.43 M | 10.5 M | 12.7 M | 8.43 M |
Book Value |
3.31 M | 10.6 M | 10.2 M | 12.3 M | 973 K | 4.95 M | 2.59 M | 7.1 M | -5.1 M | 1.85 M | 8.52 M | 14 M | 9.34 M |
Total Shareholders Equity |
3.31 M | 10.6 M | 10.2 M | 12.3 M | 973 K | 4.95 M | 2.59 M | 7.1 M | -5.1 M | 1.85 M | 8.52 M | 14 M | 9.34 M |
All numbers in USD currency
Quarterly Balance Sheet NovaBay Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
821 K | 932 K | 1.04 M | 1.11 M | 1.24 M | 1.38 M | 1.51 M | 1.59 M | 1.71 M | 1.8 M | 1.92 M | 246 K | 1 K | 5 K | 9 K | 87 K | 87 K | 87 K | 87 K | 505 K | 505 K | 1.65 M | 1.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.8 M | 4.54 M | 5.2 M | 5.72 M | 5.82 M | 7.44 M | 5.94 M | 5.84 M | 8.59 M | 5.8 M | 7.05 M | 13.8 M | 2.88 M | 2.39 M | 3.09 M | 2.92 M | 2.92 M | 2.92 M | 2.92 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 4.41 M | 4.41 M | 4.41 M | 4.41 M | 7.48 M | 7.48 M | 7.48 M | 7.48 M | 8.28 M | 8.28 M | 8.28 M | 8.28 M | 10.2 M | 10.2 M | 10.2 M | 6.01 M | 5.69 M | 5.69 M | 5.69 M | 5.69 M | 7.13 M | 7.13 M | 7.13 M | 7.13 M | 5.19 M | 5.19 M | 5.19 M | 5.19 M | 6.62 M | 6.62 M | 6.62 M | 6.62 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | 1.53 M | 1.98 M | 1.27 M | 658 K | 904 K | 795 K | 575 K | 575 K | 575 K | 575 K | 434 K | 434 K | 434 K | 434 K | 1.47 M | 1.47 M | 1.47 M | 1.47 M | 2.84 M | 2.49 M | 2.17 M | 1.67 M | 1.86 M | 1.86 M | 1.86 M | 1.86 M | 170 K | 170 K | 170 K | 425 K | 425 K | 425 K | 425 K | 425 K | 337 K | 337 K | 337 K | 337 K | 1.22 M | 1.22 M | 1.22 M | 1.22 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M |
Retained Earnings |
-182 M | -180 M | -178 M | -175 M | -166 M | -164 M | -160 M | -158 M | -150 M | -144 M | -142 M | -142 M | -142 M | -139 M | -138 M | -136 M | -136 M | -136 M | -136 M | -125 M | -125 M | -125 M | -125 M | -115 M | -115 M | -115 M | -115 M | -111 M | -111 M | -111 M | -111 M | -104 M | -104 M | -104 M | -104 M | -90.5 M | -90.5 M | -90.5 M | - | -71.5 M | -71.5 M | -71.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
3.88 M | 3.92 M | 5.36 M | 9.03 M | 12.9 M | 16 M | 14.8 M | 16.4 M | 22.4 M | 21.5 M | 24.8 M | 24 M | 12.2 M | 13.6 M | 14.1 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 9.36 M | 9.36 M | 9.36 M | 9.36 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 5.08 M | 5.08 M | 5.08 M | 8.16 M | 7.54 M | 7.54 M | 7.54 M | 7.54 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 16 M | 16 M | 16 M | 16 M |
Cash and Cash Equivalents |
776 K | 751 K | 1.82 M | 2.92 M | 3.66 M | 4.87 M | 4.17 M | 5.36 M | 3.87 M | 3.93 M | 5.64 M | 7.5 M | 9.03 M | 10.3 M | 10.5 M | 12 M | 12 M | 12 M | 12 M | 6.94 M | 6.94 M | 6.94 M | 6.94 M | 3.18 M | 3.18 M | 3.18 M | 3.18 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 9.51 M | 9.51 M | 9.51 M | 9.51 M | 2.38 M | 2.38 M | 2.38 M | 5.6 M | 5.43 M | 5.43 M | 5.43 M | 5.43 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 8.43 M | 8.43 M | 8.43 M | 8.43 M |
Book Value |
1.07 M | -617 K | 160 K | 3.31 M | 7.04 M | 8.56 M | 8.89 M | 10.6 M | 13.8 M | 15.7 M | 17.7 M | 10.2 M | 9.36 M | 11.2 M | 11 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 973 K | 973 K | 973 K | 973 K | 4.95 M | 4.95 M | 4.95 M | 4.95 M | 2.59 M | 2.59 M | 2.59 M | 2.59 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | -5.1 M | -5.1 M | -5.1 M | 2.15 M | 1.85 M | 1.85 M | 1.85 M | 1.85 M | 8.52 M | 8.52 M | 8.52 M | 8.52 M | 14 M | 14 M | 14 M | 14 M | 9.34 M | 9.34 M | 9.34 M | 9.34 M |
Total Shareholders Equity |
1.07 M | -617 K | 160 K | 3.31 M | 7.04 M | 8.56 M | 8.89 M | 10.6 M | 13.8 M | 15.7 M | 17.7 M | 10.2 M | 9.36 M | 11.2 M | 11 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 973 K | 973 K | 973 K | 973 K | 4.95 M | 4.95 M | 4.95 M | 4.95 M | 2.59 M | 1.83 M | 2.59 M | 2.59 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | -5.1 M | -5.1 M | -5.1 M | 2.15 M | 1.85 M | 1.85 M | 1.85 M | 1.85 M | 8.52 M | 8.52 M | 8.52 M | 8.52 M | 14 M | 14 M | 14 M | 14 M | 9.34 M | 9.34 M | 9.34 M | 9.34 M |
All numbers in USD currency